REGULATORY ALERT – AUSTRALIA

AusUDID: Everything Medical Device Manufacturers Need to Know Before July 2026

The TGA’s mandatory Unique Device Identification database is live — and the compliance clock is ticking for Class IIb and Class III device sponsors.

March 2026

7–10 minutes

⏱ 1 July 2026: Mandatory AusUDID compliance deadline for Class IIb & Class III medical devices

Key Fact

Over 90% of medical device ARTG entries requiring third-party certification historically rely on CE Marking certification. Australia has deliberately structured its regulatory system to make this pathway efficient.

What Is AusUDID — and Why Does It Matter?

In March 2025, the Australian Government introduced the Australian Unique Device Identification Database (AusUDID) through amendments to the Therapeutic Goods (Medical Devices) Regulations 2002. It is Australia’s national repository for UDI data — the local equivalent of the EU’s EUDAMED or the US FDA’s GUDID system.

At its core, a Unique Device Identifier (UDI) is a standardised code that allows a medical device to be precisely identified throughout the supply chain — from manufacturer through to patient. The UDI system comprises two components:

UDI-DI (Device Identifier): A fixed code identifying the specific device model or version.
UDI-PI (Production Identifier): Variable data such as lot number, serial number, or expiry date.

With AusUDID live, Australian sponsors are now required to submit their UDI-DI records — linked to their ARTG entries — into the database. The data is publicly accessible, meaning patients, clinicians, and hospital systems can look up device information directly.

the context

By introducing a UDI system, Australia joins a globally harmonised approach that enables more accurate identification, traceability, and post-market surveillance of medical devices.

For sponsors of Class IIb and Class III devices, voluntary compliance has been available since March 2025 — but mandatory compliance begins 1 July 2026. That deadline is closer than it appears once you factor in the steps required.

Who Is Affected?

If you are an Australian sponsor of any of the following, you have obligations under the AusUDID framework:

Class IIb medical devices (including implantable and non-implantable)
Class III medical devices
Active Implantable Medical Devices (AIMDs)

Lower-risk device classes (Class IIa, Class Is) have later compliance dates — but sponsors of higher-risk devices need to act now.

Are you the Australian sponsor?

Under the AusUDID framework, the Australian sponsor (the entity listed on the ARTG) is responsible for submitting UDI records and maintaining them in the database. Overseas manufacturers can assist, but the compliance obligation rests with the sponsor. If you are an overseas manufacturer without an Australian sponsor, you will need one before you can comply.

Compliance Deadlines at a Glance

Standard Compliance Timeline

For devices not relying on EU MDD transitional certificates, the standard compliance dates apply:

Requirement	Class III	Class IIb	Class IIa	Class Is
UDI Carrier on device label & packaging	1 Jul 2026	1 Jul 2026	1 Jul 2027	1 Jul 2028
Submit UDI-DI records to AusUDID	1 Jul 2026	1 Jul 2026	1 Jul 2027	1 Jul 2028
Direct Marking of reusable devices	1 Jan 2028	1 Jan 2029*	1 Jan 2029	1 Jan 2029

*Direct marking not applicable to implantable Class IIb devices.

EU MDD Transitional Arrangements

If your device is still being supplied in Australia under an EU Medical Device Directive (MDD) certificate — covered by the EU MDR transition regulation 2023/607 — extended deadlines apply:

Requirement	Class III	Class IIb implaNTBALE	Class IIB NON-IMPLANTABLE	Class IIa	Class IS
UDI Carrier on device label & packaging	1 Jan 2028	1 Jan 2028	1 Jan 2029	1 Jan 2029	1 Jan 2029
Submit UDI-DI records to AusUDID	1 Jan 2028	1 Jan 2028	1 Jan 2029	1 Jan 2029	1 Jan 2029
Direct Marking	1 Jan 2028	N/A	1 Jan 2029	1 Jan 2029	1 Jan 2029

Important: Relabelling obligation

Class IIb and Class III devices manufactured and labelled before 1 July 2026 that remain under the sponsor’s control after 1 July 2029 must be relabelled to be UDI-compliant. Devices already distributed or supplied to hospitals and patients before the compliance date are exempt for the rest of their usable life. Devices still in your warehouse are not exempt — plan accordingly.

What Data Do You Need to Submit?

Each UDI record submitted to the AusUDID must include a range of mandatory data fields, which the TGA refers to as the AusUDID Data Dictionary. At a high level, submissions must capture:

The UDI-DI code itself (issued by a TGA-recognised agency)
Device description, classification, and intended purpose
Manufacturer and sponsor details
ARTG entry number (the UDI record must be linked to your ARTG listing)
Packaging-level information (unit, case, pallet)
Clinical characteristics and production data
Direct Marking data (where applicable and once required)

UDI-DI codes must be issued by one of the three TGA-recognised issuing agencies: GS1, HIBCC, or ICCBBA. If your devices already carry a UDI for the EU or US market, those codes will typically carry over — but you must confirm the issuing agency is one the TGA recognises.

Submission Methods

The AusUDID currently supports two submission methods:

Online portal — suitable for smaller portfolios, entered device by device through the TGA’s AusUDID interface.
Bulk Upload Template — a spreadsheet-based upload that allows multiple records to be submitted at once. Recommended for sponsors with more than a handful of UDIs.

Two machine-to-machine methods (HL7 SPL and National Product Catalogue integration) are in development but not yet widely available.

Step-by-Step: The AusUDID Compliance Process

Keep records current
UDI records must be maintained over time. Any changes to the device that would require a new UDI-DI under the issuing agency’s rules also require a new AusUDID submission and re-linking.
Audit your ARTG listings
Review all your active ARTG entries and confirm which products are Class IIb or Class III and fall within the July 2026 scope. Remove any lapsed or obsolete listings before starting — you don’t want to create UDI records for products you’re no longer supplying.
Set up TGA Business Services (TBS) access
You need an active TGA Business Services (TBS) account with AusUDID access enabled. If your organisation doesn’t have a TBS account, this must be established first. Existing TBS users need to ensure their contact has the appropriate UDI submission role assigned.
Prepare and submit UDI records to AusUDID
Enter UDI-DI records via the online portal or prepare a Bulk Upload spreadsheet. Each record must include all mandatory data fields and be ready to link to your ARTG entry. The TGA’s AusUDID Pre-Production environment can be used for testing before going live.
Link UDI records to ARTG listings
Once UDI records are submitted, your Australian sponsor must link them to the corresponding ARTG listings in the AusUDID. This is a distinct step from data submission — both must be completed for full compliance.
Confirm your UDI issuing agency registration
If you don’t already have a UDI from GS1, HIBCC, or ICCBBA for your Australian products, this must be arranged first. If your devices are already MDR-compliant with a recognised UDI, verify it carries over.
Apply the UDI carrier to device labels and packaging
The UDI must appear in both human-readable (HRI) and machine-readable (AIDC/barcode) formats on the device label and all levels of applicable packaging. Implantable devices must also include the UDI on the Patient Implant Card.

Common Pitfalls to Avoid

Overlooking the MDD transition nuance. If any of your devices moved to MDR compliance earlier than the EU transitional deadline, Australian UDI requirements apply immediately — not at the extended date.

Leaving it too late. The TGA has warned of potential surges in last-minute activity. Submission queues, TGA review times, and ARTG linking can all add delays that are invisible until you’re in them.

Confusing the labelling deadline with the database deadline. Both the physical UDI label on the device and the AusUDID record submission are required by the same date — they’re separate tasks.

Assuming your EU UDI automatically transfers. EU MDR UDI-DIs issued by GS1, HIBCC, or ICCBBA will generally be accepted, but you still need to actively submit them to AusUDID and link them to your ARTG entries.

Not checking stock in transit. The compliance obligation is based on when a device is next supplied in Australia — devices in your warehouse or in transit after 1 July 2026 are in scope.

How Practical RA Can Help

Managing AusUDID submissions takes time — especially if you have a large device portfolio, limited internal regulatory bandwidth, or you’re an overseas manufacturer unfamiliar with Australia’s TGA Business Services system.

Practical RA offers a fixed-fee AusUDID managed submission service for Australian sponsors. We handle the end-to-end process: TBS account setup guidance, data preparation, bulk upload submission, and ARTG linking — so you can focus on your business while we handle the compliance.

Get Your AusUDID Submissions Done — Before the Rush

Fixed-fee service. No hourly billing surprises. We’ll manage your UDI submissions from data prep through to confirmed ARTG linking.

Request a quote→

Pricing from $950 AUD · Response within 1 business day

Our Pricing

We charge a flat fee based on the number of UDIs in your portfolio — no hourly billing, no surprises:

1–10 UDIs: $950 AUD
11–50 UDIs: $1,850 AUD
51–100 UDIs: $2,950 AUD
100+ UDIs: Custom quote

All tiers include data preparation review, bulk upload submission, and confirmation of AusUDID records. ARTG linking coordination is included as part of our Australian sponsorship service, or available separately.

Practical RA is an Australian regulatory affairs consultancy specialising in TGA medical device compliance. We act as Australian Sponsor for overseas manufacturers and provide a range of regulatory support services for the Australian and New Zealand markets.